Try our beta test site
1 study found for:    15194017 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED)
Condition: Coronary Disease
Interventions: Drug: MK0653, ezetimibe / Duration of Treatment: 27 Weeks;   Drug: MK0733, simvastatin / Duration of Treatment: 27 Weeks;   Drug: Comparator: simvastatin / Duration of Treatment: 27 Weeks

Study has passed its completion date and status has not been verified in more than two years.